Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Relamorelin acetate
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

1809080-14-5

1809080-14-5 structure

Name: Relamorelin acetate
Chemical Name: Relamorelin acetate
CAS Number: 1809080-14-5
Molecular Formula: C₄₅H₅₄N₈O₇S
Molecular Weight: 851.02
Catalog: Signaling Pathways GPCR/G Protein GHSR
Create Date: 2021-09-13 19:22:17
Modify Date: 2024-01-19 17:15:03
Relamorelin (RM-131) acetate, a Ghrelin analog, is a potent ghrelin receptor agonist, with a Ki of 0.42 nM for GHS-1a. Relamorelin acetate can promote food intake and adiposity in mice. Relamorelin acetate can be used for the research of cachexia, gastroparesis, and gastric/intestinal dysmobility disorders[1][2][3].

Name	Relamorelin acetate

Description	Relamorelin (RM-131) acetate, a Ghrelin analog, is a potent ghrelin receptor agonist, with a Ki of 0.42 nM for GHS-1a. Relamorelin acetate can promote food intake and adiposity in mice. Relamorelin acetate can be used for the research of cachexia, gastroparesis, and gastric/intestinal dysmobility disorders[1][2][3].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> GPCR/G Protein >> GHSR
Target	Ki: 0.42 nM (GHS-1a)[1]
In Vitro	Relamorelin shows ∼3 times greater affinity for GHS-1a (Ki=0.42 nM) than native ghrelin (Ki=1. 12 nM)[1]. Relamorelin is 6 times more potent (EC50=0.71 nM) in activating the GHS-1a receptor than native ghrelin (EC50=4.2 nM) as assessed in vitro by calcium mobilization[1].
In Vivo	Relamorelin (500 nmol/kg/day; continuous infusion for 5 days) increases the food intake and weight gain in rats[1]. Relamorelin (50-500 nmol/kg/day; continuous infusion for 5 days) decreases the loss of body mass and fat mass[1]. RM-131 (250-500 nmol/kg; a single s.c.) stimulates acute food intake in wt but not growth hormone secretagogue receptor (GHR) ko mice[2]. Animal Model: F344/NTacfBR male rats implanted with tumor[1] Dosage: 50, 500 nmol/kg/day Administration: Continuous infusion at a rate of 0.5 μL/h for 5 d s.c. Result: Resulted in an increase in food intake (tumor/saline 41.4 g, tumor/BIM-28131 72.5 g) and weight gain (tumor/saline -10.3%, tumor/BIM-28131 +19.5%).
References	[1]. DeBoer MD, et, al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007 Jun;148(6):3004-12. [2]. Fischer K, et, al. The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor. Front Nutr. 2015 Jan 12;1:31. [3]. Zatorski H, et, al. Relamorelin and other ghrelin receptor agonists - future options for gastroparesis, functional dyspepsia and proton pump inhibitors-resistant non-erosive reflux disease. J Physiol Pharmacol. 2017 Dec;68(6):797-805.

Molecular Formula	C₄₅H₅₄N₈O₇S
Molecular Weight	851.02

1809080-14-5	661472-41-9
6426-44-4	29066-34-0
54324-99-1	10483-91-7
6046-93-1	27569-23-9
58735-82-3	88206-47-7
1158522-08-7	940364-43-2
941925-73-1	134104-43-1
131615-57-1	899991-05-0
6906-52-1	190781-74-9
930439-75-1	1018584-77-4